Antiapoptotic action of 1α,25-dihydroxyvitamin D3 in primary human melanocytes

Melanoma Research

Volumn 13, Issue 4, 2003, Pages 339-347

  Sauer, Bettina ^a   Ruwisch, Lars ^a   Kleuser, Burkhard ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

1 ,25 dihydroxyvitamin D3; Apoptosis; Bcl 2 family; Cell growth; Melanocytes; Sphingosine 1 phosphate

Indexed keywords

CALCITRIOL; DNA; PROTEIN BAX; PROTEIN BCL 2; SPHINGOSINE 1 PHOSPHATE; BAX PROTEIN, HUMAN; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; ONCOPROTEIN; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROTECTION; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MELANOCYTE; MELANOMA; MELANOMA CELL; NICK END LABELING; PRIORITY JOURNAL; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; METABOLISM; PHYSIOLOGY; RADIATION EXPOSURE; ULTRAVIOLET RADIATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CALCITRIOL; CELL DIVISION; CELLS, CULTURED; CYTOPROTECTION; HUMANS; LYSOPHOSPHOLIPIDS; MELANOCYTES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SPHINGOSINE; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 0041365771     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200308000-00002     Document Type: Article

References (39)

1. Virador VM, Muller J, Wu X, Abdel-Malek ZA, Yu ZX, Ferrans VJ, et al. Influence of alpha-melanocyte-stimulating hormone and ultraviolet radiation on the transfer of melanosomes to keratinocytes. FASEB J 2002; 16:105-107.
2. Kvam E, Tyrrell RM. The role of melanin in the induction of oxidative DNA base damage by ultraviolet A irradiation of DNA or melanoma cells. J Invest Dermatol 1999; 113:209-213.
3. 3, alphamelanocyte stimulating hormone, and beta-estradiol. J Invest Dermatol 1988; 91:593-598.
4. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 1981; 108:1083-1086.
5. 3 metabolites. Cancer Res 1983; 43:4443-4447.
6. 3 in human malignant melanoma cell lines. J Surg Res 1996; 61:127-133.
7. 3. Cancer Res 1987; 47:21-25.
8. 3 and its analogues. Cell Death Differ 1998; 5:946-952.
9. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988; 85:3294-3298.
10. Hutchinson PE, Osborne JE, Lear JT, Smith AG, Bowers PW, Morris PN, et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 2000; 6:498-504.
11. 3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp Cell Res 1997; 235:210-217.
12. 3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp Cell Res 1993; 209:367-374.
13. 3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. Cancer Res 1998; 58:1817-1824.
14. 3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol 2001; 117:1241-1249.
15. 3-induced HL-60 cell differentiation. J Biol Chem 1990; 265:15823-15831.
16. 3 induces sphingomyelin hydrolysis in HaCaT cells via tumor necrosis factor alpha. J Biol Chem 1997; 272:8997-9001.
17. Bielawska A, Linardic CM, Hannun YA. Modulation of cell growth and differentiation by ceramide. FEBS Lett 1992; 307:211-214.
18. Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci 1995; 20:73-77.
19. 3 up-regulates Bcl-2 expression and protects normal human thyrocytes from programmed cell death. Endocrinology 1999; 140:1649-1656.
20. 3 analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase. Br J Haematol 2000; 109:576-583.
21. 3. Arch Dermatol Res 2000; 292:455-462.
22. Yamamura K, Kamada S, Ito S, Nakagawa K, Ichihashi M, Tsujimoto Y. Accelerated disappearance of melanocytes in bcl-2-deficient mice. Cancer Res 1996; 56:3546-3550.
23. 3 and antiestrogens in modulating apoptosis of breast cancer cells and tumors. Subcell Biochem 1998; 30:245-270.
24. 3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 2000; 60:2304-2312.
25. Xie SP, James SY, Colston KW. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. J Endocrinol 1997; 154:495-504.
26. Colston KW, Perks CM, Xie SP, Holly JM. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J Mol Endocrinol 1998; 20:157-162.
27. Nickerson T, Huynh H. Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins. J Endocrinol 1999; 160:223-229.
28. 3 potentiates the cytotoxic effect of TNF on human breast cancer cells. Mol Cell Endocrinol 1994; 106:157-162.
29. 3 analogue, calcipotriol, induces sphingomyelin hydrolysis in human keratinocytes. FEBS Lett 1996; 378:88-92.
30. Gamard CJ, Dbaibo GS, Liu B, Obeid LM, Hannun YA. Selective involvement of ceramide in cytokine-induced apoptosis. Ceramide inhibits phorbol ester activation of nuclear factor kappaB. J Biol Chem 1997; 272:16474-16481.
31. Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S, et al. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 1995; 92:8443-8447.
32. Kolesnick RN, Haimovitz-Friedman A, Fuks Z. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem Cell Biol 1994; 72:471-474.
33. 2. Cell Death Differ 1999; 6:890-901.
34. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso CA, Gutkind S, et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996; 381:800-803.
35. Edsall LC, van Brocklyn JR, Cuvillier O, Kleuser B, Spiegel S. N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 1998; 37:12892-12898.
36. Mathiasen IS, Lademann U, Jaattela M. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res 1999; 59:4848-4856.
37. Narvaez CJ, Welsh J. Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem 2001; 276:9101-9107.
38. Pirianov G, Colston KW. Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis. Mol Cell Endocrinol 2001; 172:69-78.
39. Goetzl EJ, Kong Y, Mei B. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J Immunol 1999; 162:2049-2056.